Home › Funds › Rubric Capital Management LP › INDV
Rubric Capital Management LP position in INDV
INDIVIOR PHARMACEUTICALS INC · Health Care
Rubric Capital Management LP reported holding 3,862,989 shares of INDV (INDIVIOR PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$138.5M, representing 1.31% of its reported portfolio and ranking #22 among its reported holdings. Rubric Capital Management LP has disclosed INDV holdings in 7 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Rubric Capital Management LP's INDV position evolved
Rubric Capital Management LP first disclosed a stake in INDV in Q4 2024 at 1,360,000 shares (US$16.9M). The position peaked in Q3 2026 at 3,862,989 shares, worth US$138.5M. Across 7 filings, Rubric Capital Management LP increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 3,862,989 shares valued at US$138.5M. Notable position changes include a 160% increase in Q1 2025 (shares rose 55% over the following quarter), a 76% trim in Q3 2025 (shares rose 49% over the following quarter), a 56% trim in Q4 2025 (shares fell 15% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 1.36M | $16.90M | New |
| Q1 2025 | 3.53M | $33.64M | Add |
| Q2 2025 | 4.65M | $68.50M | Add |
| Q3 2025 | 1.13M | $27.27M | Reduce |
| Q4 2025 | 498.53K | $17.89M | Reduce |
| Q1 2026 | 662.51K | $20.19M | Add |
| Q3 2026 | 3.86M | $138.49M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About INDV and 13F data
INDV (INDIVIOR PHARMACEUTICALS INC) is a Health Care company. 46 other funds we track also report a position in INDV — the largest reported positions include OAKTREE CAPITAL MANAGEMENT LP (US$251.4M), MILLENNIUM MANAGEMENT LLC (US$225.2M), Madison Avenue Partners, LP (US$173.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding INDV
- OAKTREE CAPITAL MANAGEMENT LP 6.13M sh · $251.40M · Q2 2026
- MILLENNIUM MANAGEMENT LLC 6.28M sh · $225.22M · Q3 2026
- Madison Avenue Partners, LP 4.85M sh · $173.94M · Q3 2026
- Two Seas Capital LP 3.67M sh · $131.61M · Q3 2026
- Jones Hill Capital LP 1.53M sh · $54.73M · Q3 2026
- Divisadero Street Capital Management, LP 1.47M sh · $52.72M · Q3 2026
- Newtyn Management, LLC 1.31M sh · $46.81M · Q3 2026
- GENDELL JEFFREY L 1.15M sh · $41.10M · Q3 2026
- MANGROVE PARTNERS IM, LLC 1.13M sh · $40.68M · Q3 2026
- OBERWEIS ASSET MANAGEMENT INC/ 945.55K sh · $33.90M · Q3 2026
- Westchester Capital Management, LLC 775.86K sh · $27.81M · Q3 2026
- PFM Health Sciences, LP 741.86K sh · $26.60M · Q3 2026
More on Rubric Capital Management LP
FAQ
How long has Rubric Capital Management LP held INDV?
Rubric Capital Management LP has disclosed INDV holdings in 7 of the last 8 reported quarters, going back to Q4 2024.
What is Rubric Capital Management LP's current position in INDV?
As of Q3 2026, Rubric Capital Management LP holds 3.86M shares of INDV (INDIVIOR PHARMACEUTICALS INC), valued at $138.49M, representing 1.31% of its reported portfolio and ranking #22.
Has Rubric Capital Management LP been buying or selling INDV?
In the latest 13F filing (Q3 2026), Rubric Capital Management LP newly opened its position in INDV. The position peaked in Q3 2026 at 3.86M shares.
Which other funds hold INDV?
Other major institutional holders of INDV include OAKTREE CAPITAL MANAGEMENT LP, MILLENNIUM MANAGEMENT LLC, Madison Avenue Partners, LP, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.